A lifetime aging study of human CD19 transgenic mice

Area of Science:

• Immunology
• Transgenic Animal Models
• B Lymphocyte Biology

Background:

• CD19 is crucial for B lymphocyte function.
• Lifetime studies of CD19 transgenic mice on a C57BL/6J background were lacking.
• Understanding CD19 overexpression effects on survival and pathology is important.

Purpose of the Study:

• To assess the lifetime effects of CD19 overexpression on mouse health.
• To evaluate clinical signs, body weight, survival, and spontaneous pathology.
• To characterize the impact on B lymphocyte function and related diseases.

Main Methods:

• Conducted a lifetime study with interim sacrifices in CD19 transgenic mice.
• Collected blood and urine for clinical pathology analysis.
• Performed macroscopic and microscopic examinations at predetermined intervals.

Main Results:

• Mice exhibited fair survival, reaching up to 108 weeks.
• Observed regenerative anemia, altered white blood cell counts, and declining glucose.
• Increased urinary microalbumin correlated with glomerulopathy; common neoplasms included lung adenomas and histiocytic sarcoma.

Conclusions:

• CD19 overexpression impacts B lymphocyte function and overall health in mice.
• The study identified specific pathologies and neoplasms associated with CD19 transgenic status.
• These findings provide insights into CD19's role in health and disease progression.